Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $48.98 USD
Change Today +0.43 / 0.89%
Volume 2.5M
ZTS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Catherine A. Knupp

President of Research & Development and Executive Vice President, Zoetis Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$1,620,696
As of Fiscal Year 2014

Background*

Dr. Catherine A. Knupp has been the President of Research & Development and an Executive Vice President of Zoetis Inc. since October 2012 and she leads its Global R&D function. Dr. Knupp served as Vice President of Pfizer’s Veterinary Medicine Research and Development business unit from 2005 to 2012. Dr. Knupp joined Pfizer in July 2001 and held various positions, including Vice President of Pfizer’s Michigan laboratories for Pharmacokinetics, Dynamics and Metabolism. ...

Read Full Background

Corporate Headquarters*

100 Campus Drive
Florham Park, New Jersey 07932

United States

Phone: 973-822-7000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$451,375
Total Annual Compensation$451,375

Stock Options*

Restricted Stock Awards$374,974
All Other Compensation$67,278
Unexercisable Options89,612
Unexercisable Options Value$1,297,162
Total Value of Options$1,297,162
Total Number of Options89,612

Total Compensation*

Total Annual Cash Compensation$870,726
Total Short Term Compensation$451,375
Other Long Term Compensation$442,252
Total Calculated Compensation$1,620,696
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZTS:US $48.98 USD +0.43

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clinton H. Severson Chairman and Chief Executive Officer
Abaxis, Inc.
$800.5K
Jonathan W. Ayers Chairman, Chief Executive Officer and President
IDEXX Laboratories, Inc.
$800.0K
Jack Clifford Bendheim Chairman, Chief Executive Officer, President, Member of Compensation Committee and Member of Retirement Benefits Committee
Phibro Animal Health Corporation
$3.0M
Matthieu Frechin Chief Executive Officer, Director and Member of Strategy Committee
Vétoquinol SA
€395.3K
Éric Marée Chairman of the Executive Board, Chief Executive Officer, President and Chairman of Strategic Committee
Virbac SA
€529.6K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOETIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.